About Keratin, type I cytoskeletal 40
Keratin, type I cytoskeletal 40 (KRT40) is a protein
from Homo sapiens identified by UniProt accession
Q6A162, 431 residues long.
MolForge cross-references it against 0 known binders and
16 disease associations.
Target properties
| Protein name | Keratin, type I cytoskeletal 40 |
| UniProt accession | Q6A162 |
| Gene | KRT40 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (16)
Diseases linked to this target (Open Targets).
- glioblastoma multiforme · score 0.19
- head and neck squamous cell carcinoma · score 0.18
- esophageal cancer · score 0.14
- gonorrhea · score 0.02
- neoplasm · score 0.01
- type 2 diabetes mellitus · score 0.00
- hepatocellular carcinoma · score 0.00
- heart disease · score 0.00
- progeria · score 0.00
- neuroendocrine neoplasm · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6A162-F1 | alphafold | PREDICTED | 76.11 | — |
Amino-acid sequence (431 residues)
MTSDCSSTHC SPESCGTASG CAPASSCSVE TACLPGTCAT SRCQTPSFLS RSRGLTGCLL PCYFTGSCNS PCLVGNCAWC EDGVFTSNEK ETMQFLNDRL ASYLEKVRSL EETNAELESR IQEQCEQDIP MVCPDYQRYF NTIEDLQQKI LCTKAENSRL AVQLDNCKLA TDDFKSKYES ELSLRQLLEA DISSLHGILE ELTLCKSDLE AHVESLKEDL LCLKKNHEEE VNLLREQLGD RLSVELDTAP TLDLNRVLDE MRCQCETVLA NNRREAEEWL AVQTEELNQQ QLSSAEQLQG CQMEILELKR TASALEIELQ AQQSLTESLE CTVAETEAQY SSQLAQIQCL IDNLENQLAE IRCDLERQNQ EYQVLLDVKA RLEGEINTYW GLLDSEDSRL SCSPCSTTCT SSNTCEPCSA YVICTVENCC L
Explore Keratin, type I cytoskeletal 40 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets